Roth Capital Issues Pessimistic Estimate for Tilray Earnings

Tilray Inc (NASDAQ:TLRY) – Analysts at Roth Capital dropped their FY2025 earnings per share estimates for Tilray in a research note issued to investors on Sunday, January 12th. Roth Capital analyst W. Kirk now forecasts that the company will post earnings per share of ($0.23) for the year, down from their prior estimate of ($0.18). The consensus estimate for Tilray’s current full-year earnings is ($0.14) per share.

Other research analysts have also recently issued reports about the company. Roth Mkm reduced their price objective on Tilray from $2.00 to $1.75 and set a “neutral” rating for the company in a research note on Friday, October 11th. Canaccord Genuity Group raised their price objective on Tilray from $2.00 to $3.00 and gave the stock a “buy” rating in a research note on Monday. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $2.70.

Tilray Stock Performance

Tilray stock opened at $1.18 on Wednesday. The stock has a 50-day moving average of $1.33 and a two-hundred day moving average of $1.61. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.57 and a current ratio of 2.47. Tilray has a one year low of $1.14 and a one year high of $2.97. The stock has a market cap of $1.07 billion, a PE ratio of -4.37 and a beta of 2.08.

Tilray (NASDAQ:TLRY) last released its quarterly earnings results on Friday, January 10th. The company reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.07). Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. The business had revenue of $210.90 million during the quarter, compared to analysts’ expectations of $216.34 million. The company’s revenue was up 8.7% compared to the same quarter last year.

Institutional Trading of Tilray

Several hedge funds and other institutional investors have recently bought and sold shares of TLRY. BNP Paribas Financial Markets grew its holdings in Tilray by 1,314.1% during the third quarter. BNP Paribas Financial Markets now owns 1,819,494 shares of the company’s stock worth $3,202,000 after acquiring an additional 1,690,827 shares during the period. Point72 Asset Management L.P. acquired a new stake in Tilray during the third quarter worth about $1,348,000. Bank of Montreal Can grew its holdings in Tilray by 19.6% during the second quarter. Bank of Montreal Can now owns 2,169,100 shares of the company’s stock worth $3,622,000 after acquiring an additional 355,778 shares during the period. XTX Topco Ltd grew its holdings in Tilray by 1,079.7% during the third quarter. XTX Topco Ltd now owns 281,504 shares of the company’s stock worth $495,000 after acquiring an additional 257,641 shares during the period. Finally, Barclays PLC grew its holdings in Tilray by 600.4% during the third quarter. Barclays PLC now owns 204,144 shares of the company’s stock worth $359,000 after acquiring an additional 174,997 shares during the period. 9.35% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Tilray

In related news, CFO Carl A. Merton bought 26,000 shares of the company’s stock in a transaction that occurred on Friday, November 15th. The shares were purchased at an average cost of $1.36 per share, with a total value of $35,360.00. Following the completion of the acquisition, the chief financial officer now directly owns 26,000 shares in the company, valued at approximately $35,360. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.87% of the company’s stock.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.